Gene · 325
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report. | BMC Nephrol | 2023 | 37365566 | PubTator, text mining | PubMed |
| Proteomic-based identification of APCS as candidate protein for diagnosis of patients exhibiting anti-tubercular drug induced liver injury. | Sci Rep | 2023 | 37349331 | PubTator, text mining | PubMed |
| Serum Amyloid P Attenuates Hypertrophic Scarring in Large Animal Models. | J Surg Res | 2023 | 37327638 | PubTator, text mining | PubMed |
| Experimental Analysis of Tear Fluid and Its Processing for the Diagnosis of Multiple Sclerosis. | Sensors (Basel) | 2023 | 37299978 | PubTator, text mining | PubMed |
| Ganglioside GM1 and the Central Nervous System. | Int J Mol Sci | 2023 | 37298512 | PubTator, text mining | PubMed |
| Hemiplegic Migraine in Children and Adolescents. | J Clin Med | 2023 | 37297978 | PubTator, text mining | PubMed |
| Humoral Immunity Against Aspergillus fumigatus. | Mycopathologia | 2023 | 37289362 | PubTator, text mining | PubMed |
| Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases. | Front Immunol | 2023 | 37256139 | PubTator, text mining | PubMed |
| Three Major Causes of Metabolic Retinal Degenerations and Three Ways to Avoid Them. | Int J Mol Sci | 2023 | 37240082 | PubTator, text mining | PubMed |
| Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA review. | Alzheimers Res Ther | 2023 | 37226162 | PubTator, text mining | PubMed |
| Eosinophilic granulomatosis with polyangiitis - Advances in pathogenesis, diagnosis, and treatment. | Front Med (Lausanne) | 2023 | 37215720 | PubTator, text mining | PubMed |
Regenerative biomineralization potential of commercially available remineralizing agents as a preventive treatment approach for tooth erosion - An in vitro laser-induced breakdown spectroscopy analysis. | J Conserv Dent | 2023 | 37205890 | PubTator, text mining | PubMed |
| Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping. | JACC Cardiovasc Imaging | 2023 | 37178079 | PubTator, text mining | PubMed |
| Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial. | Haematologica | 2023 | 37165840 | PubTator, text mining | PubMed |
| ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics. | Acta Neuropathol Commun | 2023 | 37158955 | PubTator, text mining | PubMed |
| Monomeric C-reactive protein: A novel biomarker predicting neurodegenerative disease and vascular dysfunction. | Brain Pathol | 2023 | 37158450 | PubTator, text mining | PubMed |
A pilot randomized clinical trial of biomedical link with mental health in art therapy intervention programs for alcohol use disorder: Changes in NK cells, addiction biomarkers, electroencephalography, and MMPI-2 profiles. | PLoS One | 2023 | 37146054 | PubTator, text mining | PubMed |
| Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide 124I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging. | Pharmaceuticals (Basel) | 2023 | 37111386 | PubTator, text mining | PubMed |
| Treatment of amyloidosis: present and future. | Eur Heart J Suppl | 2023 | 37091663 | PubTator, text mining | PubMed |
| Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis. | Eur Heart J Suppl | 2023 | 37091656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/325/papers?page=10